Week 2

Crystals and Cancer

Semester:

On September 9, 2010, Charles E Dann III presented his topic on Structure-based Drug Design: Human Folate Receptors and Cancer. Charles has his PhD and is involved in the chemistry department at Indiana University. The purpose of his talk was to discuss a new possible anti-cancer treatment with the help of light. Fluoresce, the process of shining light on a subject to excite the electrons into a higher energy state, can help identify the problem areas that may lead to cancer. 

Human Folate Receptors and Cancer

Semester:

            On September 9, Charles Dann III gave his presentation on “Structure-based Drug Design: Human Folate Receptors & Cancer.” Dann received a degree in chemistry from Millsaps College in Jackson, Mississippi and earned his Ph.D. at Johns Hopkins University School of Medicine in Baltimore, Maryland. He now researches in the chemistry department at Indiana University in Bloomington, Indiana.

Structure Based Drug Design

Semester:

The second week of ChemSem brough Charles Dann III to present his research from Indiana University. In the past couple of years Dann has been working with a graduate student to further modern science's understanding of folic acid and antifolates as they interact in the body. Through research in the past, it has become clear that antifolates play an important role in biological functions, especially as they come to relate to cancer and the search for a cure.

Human Folate Receptors and Cancer

Semester:

 

On September 9, Dr. Charles Dann passed by our chemistry amphitheater here at Andrews University to tell us a little bit about Structure Based Design: Human Folate Receptors and Cancer.

Once again, I must admit I felt as if I would be blown away by this topic. After I picking up a few handouts from the back of the room, Dr. Dann began his presentation on Folates and cancer. He mentioned that the goal of his research was to derive anti-folates that could potentially treat diseases. He also mentioned that anti folates were used in treatments of leprosy.

Structured-based drug design: Human Folate receptors and Cancer

Semester:

on 9/9/10, a speaker by the name of Charles Dann III came to our chemistry seminar session and talked about the Structured-based drug design: human Folate receptors and Cancer. He was a tall caucasian male in his late 30's. He spoke clearly and I thought he had a great "stage personality".

Pages